TITLE:
      Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
SUMMARY:
      This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc
      dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid
      function in subjects with autoimmune thyroiditis.
DETAILED DESCRIPTION:
      This is a 5-visit, 12-week, double-blind, randomized, placebo-controlled, parallel-group
      study.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  adults 18-70 years of age

          -  having positive antibodies against thyroid peroxidase

          -  having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis

        Exclusion Criteria:

          -  having evidence of end-stage thyroiditis

          -  being a current smoker or smokeless tobacco user

          -  be taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or
             anti-CTLA-4 antibody

          -  be taking any medication for treatment of autoimmune thyroiditis other than
             L-thyroxine or equivalent
